Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 7, 2016; 22(1): 300-325
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.300
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.300
Transgene | Promoter | Expression | Pathology | Ref. |
PreS/S/X | Endogenous | Surface proteins | Until 6 mo: no obvious pathology | [28] |
PreS/S/X (two TGs) | Endogenous and mouse metallothionein I | Surface proteins | Not determined | [29] |
PreS/S/X | Mouse metallothionein I and Albumin | Surface proteins | Ground glass | [22,30-32,34] |
7-9 mo: adenoma | ||||
12 mo: HCC | ||||
18 mo: HCC (100%) | ||||
Genome (2X) | Endogenous | Surface proteins | Not determined | [241] |
PreS/S (Knock-in) | Mouse p21 | Surface proteins | 15-24 mo: HCC [53% (♂KI/+), 72% (♂KI/KI), 0% (♀KI/+ and KI/KI)] | [37] |
PreS/S | Endogenous | Surface proteins | HCC | [33,40] |
X | Human α-1-antitrypsin | HBx protein | Focal necrosis, hyperplasia nodule (Authors claimed that X is not tumorigenic) | [42] |
X | Endogenous | HBx protein | 4 mo: altered hepatocyte in multifocal area | [43,44] |
10 mo: tumor nodule | ||||
16 mo: tumor (80%) | ||||
24 mo: HCC (84%) | ||||
X | Endogenous | HBx protein | 6 mo: neoplastic nodules (66.6%) | [41] |
15-18 mo: small neoplastic nodule (100%) and HCC (75%) | ||||
X (Knock-in) | Mouse p21 | HBx protein | 15-24 mo: HCC [60%-64% (♂KI/+ and KI/KI), 43%-46% (♀KI/+ and KI/KI)] | [37] |
X | Mouse albumin | HBx protein | 12 mo: dysplasia nodule (100%) | [45-47] |
16 mo: HCC (80%) | ||||
20 mo: HCC (90%-100%) | ||||
Precore/core | Mouse metallothionein I | Precore protein | Not determined | [56] |
Precore/core | Endogenous | Core protein | 12 mo: no hepatitis or HCC | [13,57] |
Precore/core (two TGs) | Endogenous | Precore and core proteins | Not determined | [58] |
Genome (2X) | Endogenous | Replicative intermediates | 10 mo: no obvious pathology | [60] |
Genome (1.2X) | Endogenous | Replicative virus | 12 mo: no hepatitis or HCC | [59,61] |
24 mo: no obvious pathology | ||||
Genome (1.3X) | Endogenous | Replicative intermediates | Until 12 mo: no obvious pathology | [62] |
- Citation: Teng YC, Shen ZQ, Kao CH, Tsai TF. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. World J Gastroenterol 2016; 22(1): 300-325
- URL: https://www.wjgnet.com/1007-9327/full/v22/i1/300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i1.300